Opendata, web and dolomites

BEEOXAL

Treatment against honeybee varroosis based on highly effective application of oxalic acid through sublimation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BEEOXAL project word cloud

Explore the words cloud of the BEEOXAL project. It provides you a very rough idea of what is the project "BEEOXAL" about.

combining    yearly    mono    worldwide    pellets    secure    maximising    tablet    negative    million    beekeeping    handling    safe    sl    vast    hive    unlike    soluciones    device    cenavisa    network    severe    beekeepers    pest    dosage    dose    sublimate    consists    honey    delivering    safely    medicament    countries    therapeutic    ap    population    causing    health    sme    biodiversity    provides    outmatches    treatment    humans    effectiveness    cumulative    cloud    efficacy    times    inside    acid    nature    agent    12    spanish    sagavet    animal    sublimates    generating    margin    iacute    annual    agriculture    pollination    payback    33    anti    seconds    international    197    optimal    doses    environment       burns    resistance    natural    organic    serious    medicaments    beeoxal    backed    colas    oxalic    2020    2022    residue    disease    ensures    16    decline    kit    honeybees    burner    either    forecasts    spread    varroosis    thanks    eight    none    x6    revenue    treatments    wildlife    formulation    solutions    96    compulsory    honeybee    mixing    byopic    2014    jobs    guarantee    synthetic    faster    spot    homogeneous    ready   

Project "BEEOXAL" data sheet

The following table provides information about the project.

Coordinator
SAGAVET SOLUCIONES S.L. 

Organization address
address: C/ BALANCO I BOTER 22, ATICO, PLANTA 2A
city: MATARO BARCELONA
postcode: 8302
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://sagavetsoluciones.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.5. (SOCIETAL CHALLENGES - Climate action, Environment, Resource Efficiency and Raw Materials)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2017-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SAGAVET SOLUCIONES S.L. ES (MATARO BARCELONA) coordinator 50˙000.00

Map

 Project objective

Varroosis is the most serious honeybee disease worldwide, causing €197 million loss yearly in the eight main European beekeeping countries, and severe population decline of this main pollination agent, with strong impact on agriculture and wildlife biodiversity. Negative effects are of such extent that the EU provides specific funding (€33.1 M, 2014-16), to support beekeepers applying compulsory annual anti-varroosis treatments, but current medicaments cannot effectively control varroosis because none, either synthetic of organic, guarantee all the features required for optimal pest control: 1) High efficacy; 2) natural and safe for humans, honeybees and environment; 3) no resistance development; 4) Easy-to-use. BEEOXAL outmatches existing solutions by combining these four features. It consists of a treatment kit with (1) easy-to-use mono-dose pellets and (2) a specifically developed device that burns (sublimates) the tablet so it is spread like a cloud inside the hive. BEEOXAL results from the research and vast field experience of Sagavet Soluciones SL, a Spanish SME delivering animal health solutions. Based on a component already present in honey, oxalic acid, BEEOXAL has an efficacy of 96.8%, a large therapeutic margin thanks to improved spot-on formulation and dosage. Unlike synthetic products, BEEOXAL’s organic nature ensures no residue. The ready-for-use mono-dose pellets do not require mixing or handling, and the burner device to directly sublimate the tablet inside each hive allows a homogeneous distribution of the medicament in 30 seconds (x6 times faster than current treatments). This is crucial since it allows beekeepers to work safely and to avoid under/over doses (secure), maximising overall effectiveness. Backed by its international network (Cenavisa, Byopic), Soluciones Apícolas forecasts €6.8 million cumulative revenue for 2020-2022, and payback of 1 year, while generating 12 new jobs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BEEOXAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BEEOXAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.5.;H2020-EU.2.3.1.)

APA (2018)

Filter-less water-based Air Pollution Abatement system

Read More  

NATEDE (2017)

Nature, Technology and Design

Read More  

LEAP home (2017)

LEAP home, a new home for a sustainable future. A functional and aesthetic answer to a liberated living.

Read More